A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models

Yanlan Yu, Pierre Lee, Yaohuang Ke et al. · 2010

Read A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models by Yanlan Yu, Pierre Lee, Yaohuang Ke et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009072.txt.

Description

Yanlan Yu and co-authors rebuilt a rabbit antibody so it could treat human tumours in mice, in PLOS ONE in 2010. Rabbit antibodies bind targets with prized precision and strength. Those traits suit lab tests, but rabbit proteins were unused as human medicines. The target was VEGF, a signal tumours use to grow blood vessels.

Humanising the antibody kept its grip while making it body-friendly. In mice carrying human tumours, it blocked new vessel growth. Tumour growth slowed as its blood supply was choked. The study opens rabbit antibodies as a source of future cancer drugs.

Catalog record

CREATORYanlan Yu, Pierre Lee, Yaohuang Ke et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009072

Browse the full library · About the Tower of Babel